Ass. Prof. Chad Carroll (USA)
Serum AGEs as potential mediators of delayed tendon healing and disease pathogenesis with diabetes 
The long-term goal of Dr. Carroll’s research is to determine the mechanisms contributing to poor tendon health, particularly in persons with diabetes, and discover approaches for normalizing tendon function. Dr. Carroll’s multi-faceted research portfolio has projects focused on endogenous circulating mediators of tendon pathology. These mediators include advanced glycation end-products and hormones such as estrogen. Dr. Carroll’s work spans the translational spectrum – from molecular biology experiments to test disease mechanisms to human clinical trials to test treatment efficacy.